[HTML][HTML] Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases

VJ Escudero-Saiz, Á Gonzalez, A García-Herrera… - Kidney Medicine, 2024 - Elsevier
C3 glomerulopathy is a rare disease caused by fluid phase dysregulation of the alternative
complement pathway. Currently, treatment depends on clinical and histological severity and …

Second and third generational advances in therapies of the immune-mediated kidney diseases in children and adolescents

R Grenda, Ł Obrycki - Children, 2022 - mdpi.com
Therapy of immune-mediated kidney diseases has evolved during recent decades from the
non-specific use of corticosteroids and antiproliferative agents (like cyclophosphamide or …

C3 glomerulopathy in children: Is there still a place for anti‐cellular immunosuppression?

N Kojc, A Bahovec, TK Levart - Nephrology, 2019 - Wiley Online Library
Aim To contribute additional clinical experience to the paucity of reports on C3
glomerulopathy (C3GP) in children, we are reporting our cohort of 11 children with C3GP …

生物制剂在原发性肾病综合征中的应用

王倩汇, 刘飞, 傅海东, 毛建华 - 临床儿科杂志, 2022 - jcp.xinhuamed.com.cn
原发性肾病综合征(INS) 是儿童时期最常见的肾小球疾病, 频复发, 激素依赖,
激素抵抗等难治性肾病综合征仍是目前临床INS 治疗的难点, 近年来国内外陆续有文献报道利妥 …

Eculizumab in post-transplant C3 glomerulonephritis caused by a C3 mutation

JS Kim, KW Foster, SG Westphal - Clinical nephrology, 2020 - search.proquest.com
C3 glomerulonephritis (C3GN) is a disorder of excess alternative complement activation
leading to glomerular injury. Following kidney transplantation, C3GN has a high recurrence …

Membranoproliferative Glomerulonephritis

F Fabrizi, P Messa - Evidence‐Based Nephrology, 2022 - Wiley Online Library
Based on the results provided by electron microscopy, membranoproliferative
glomerulonephritis (MPGN) has been conventionally categorized as primary type I, type II, or …

Diagnose und Therapie glomerulärer Erkrankungen mit einem membranoproliferativen Läsionsmuster (MPGN)–2023

M Rudnicki, M Windpessl, K Eller, B Odler… - Wiener klinische …, 2023 - Springer
Die membranoproliferative Glomerulonephritis (MPGN) repräsentiert eine heterogene
Gruppe von Erkrankungen. Das gemeinsame Merkmal eines membranoproliferativen …

C3 glomerulopathy: experience of a pediatric nephrology center

F Yazılıtaş, E Kargın Çakıcı, ED Kurt Şükür… - Acta Clinica …, 2021 - Taylor & Francis
ABSTRACT Background: C3 glomerulopathy (C3G) is an uncommon disease characterized
by the deposition of complement factors in the glomeruli due to overactivation and …

Glomerulonephritis with isolated C3 deposits as a manifestation of subtotal factor I deficiency

I Boudhabhay, V Frémeaux-Bacchi… - Kidney International …, 2019 - Elsevier
The complement system is an essential effector of innate immunity that plays a crucial role in
the defense against common pathogens and in host homeostasis. 1 Therefore, patients with …

Morphofunctional effects of C5 convertase blockade in immune complex-mediated membranoproliferative glomerulonephritis: report of two cases with evidence of …

C Carrara, MA Podestà, M Abbate, P Rizzo, R Piras… - Nephron, 2020 - karger.com
A membranoproliferative pattern of glomerular injury is frequently observed in patients with
complement-mediated disorders, such as C3 glomerulopathies (C3G) and primary immune …